A New Dawn for Narcolepsy: Understanding Alixorexton's Promise
Alixorexton, a new drug for narcolepsy type 1, shows great promise. It helps patients stay awake longer (28 mins, considered normal), reduces sleepiness, cataplexy, fatigue, and improves focus. It's well-tolerated and moving to Phase 3, signaling a potential new era for treatment.
This post is for paying subscribers only
Already have an account? Sign in.